Verge Genomics Funding & Investors
Verge Genomics is a next-generation biopharmaceutical start-up using systems biology to accelerate development of life-saving treatments for neurodegenerative diseases.
vergegenomics.comTotal Amount Raised: $134,120,000
Verge Genomics Funding Rounds
Series B
$98,000,000
Series B Investors
Tao Capital PartnersVulcan CapitalAlumni VenturesEli LillyMerckSection 32Lifeforce CapitalALS Investment FundBlackRockThreshold VenturesSeries A
$32,000,000
Series A Investors
Tao Capital PartnersAlumni VenturesLifeforce CapitalCastor VenturesALS Investment FundThreshold VenturesWuXi AppTec CoBasis Set VenturesAgent CapitalJonathan DowneyGreat Oaks Venture CapitalFitz Gate VenturesOS FundSeed
$4,000,000
Seed Investors
IA VenturesTwo Sigma VenturesSlow VenturesKarlin VenturesKimberly VogelRefactor CapitalGreat Oaks Venture CapitalLifeforce CapitalDraper AssociatesOS FundPre Seed
$120,000
Pre Seed Investors
Y Combinator
Funding info provided by Diffbot.